These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 8968342)
1. In vivo 125I-erythropoietin pharmacokinetics are unchanged after anesthesia, nephrectomy and hepatectomy in sheep. Widness JA; Veng-Pedersen P; Schmidt RL; Lowe LS; Kisthard JA; Peters C J Pharmacol Exp Ther; 1996 Dec; 279(3):1205-10. PubMed ID: 8968342 [TBL] [Abstract][Full Text] [Related]
2. Changes in erythropoietin pharmacokinetics following busulfan-induced bone marrow ablation in sheep: evidence for bone marrow as a major erythropoietin elimination pathway. Chapel S; Veng-Pedersen P; Hohl RJ; Schmidt RL; McGuire EM; Widness JA J Pharmacol Exp Ther; 2001 Aug; 298(2):820-4. PubMed ID: 11454947 [TBL] [Abstract][Full Text] [Related]
3. Comparative pharmacokinetics and distribution of human urinary erythropoietin and recombinant human erythropoietin in rats. Kinoshita H; Ohishi N; Kato M; Tokura S; Okazaki A Arzneimittelforschung; 1991 Sep; 41(9):1004-7. PubMed ID: 1796912 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and distribution of recombinant human erythropoietin in rats with renal dysfunction. Kinoshita H; Ohishi N; Tokura S; Okazaki A Arzneimittelforschung; 1992 May; 42(5):682-6. PubMed ID: 1530684 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and distribution of recombinant erythropoietin in rats. Kinoshita H; Ohishi N; Kato M; Tokura S; Okazaki A Arzneimittelforschung; 1992 Feb; 42(2):174-8. PubMed ID: 1610430 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of recombinant human erythropoietin in rabbits and 3/4 nephrectomized rats. Yoon WH; Park SJ; Kim IC; Lee MG Res Commun Mol Pathol Pharmacol; 1997 May; 96(2):227-40. PubMed ID: 9226757 [TBL] [Abstract][Full Text] [Related]
7. Distribution of recombinant human erythropoietin following multiple intravenous administration and effects of age on the distribution in rats. Kinoshita H; Ohishi N; Kato M; Tokura S; Okazaki A Arzneimittelforschung; 1992 Apr; 42(4):579-84. PubMed ID: 1642686 [TBL] [Abstract][Full Text] [Related]
8. Developmental differences in erythropoietin pharmacokinetics: increased clearance and distribution in fetal and neonatal sheep. Widness JA; Veng-Pedersen P; Modi NB; Schmidt RL; Chestnut DH J Pharmacol Exp Ther; 1992 Jun; 261(3):977-84. PubMed ID: 1602403 [TBL] [Abstract][Full Text] [Related]
9. A sensitive and specific erythropoietin immunoprecipitation assay: application to pharmacokinetic studies. Widness JA; Schmidt RL; Veng-Pedersen P; Modi NB; Sawyer ST J Lab Clin Med; 1992 Mar; 119(3):285-94. PubMed ID: 1311741 [TBL] [Abstract][Full Text] [Related]
10. Immunological response to repeated administration of recombinant human erythropoietin in rats: biphasic effect on its pharmacokinetics. Kato M; Miura K; Kamiyama H; Okazaki A; Kumaki K; Kato Y; Sugiyama Y Drug Metab Dispos; 1997 Sep; 25(9):1039-44. PubMed ID: 9311618 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of erythropoietin in intact and anephric dogs. Fu JS; Lertora JJ; Brookins J; Rice JC; Fisher JW J Lab Clin Med; 1988 Jun; 111(6):669-76. PubMed ID: 3373111 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of erythropoietin in genetically anemic mice. Kato M; Miura K; Kamiyama H; Okazaki A; Kumaki K; Kato Y; Sugiyama Y Drug Metab Dispos; 1998 Feb; 26(2):126-31. PubMed ID: 9456298 [TBL] [Abstract][Full Text] [Related]
13. Role of antennary structure of N-linked sugar chains in renal handling of recombinant human erythropoietin. Misaizu T; Matsuki S; Strickland TW; Takeuchi M; Kobata A; Takasaki S Blood; 1995 Dec; 86(11):4097-104. PubMed ID: 7492766 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and haematological parameters of recombinant human erythropoietin after subcutaneous administrations in horses. Souillard A; Audran M; Bressolle F; Jaussaud P; Gareau R Biopharm Drug Dispos; 1996 Dec; 17(9):805-15. PubMed ID: 8968532 [TBL] [Abstract][Full Text] [Related]
15. Preparation of iodine labeled recombinant human erythropoietin. Kinoshita H; Ohishi N; Okazaki A Arzneimittelforschung; 1991 May; 41(5):568-70. PubMed ID: 1898429 [TBL] [Abstract][Full Text] [Related]
16. Liver as the primary site of erythropoietin formation in the fetus. Zanjani ED; Poster J; Burlington H; Mann LI; Wasserman LR J Lab Clin Med; 1977 Mar; 89(3):640-4. PubMed ID: 839121 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic/pharmacodynamic analysis of paradoxal regulation of erythropoietin production in acute anemia. Al-Huniti NH; Widness JA; Schmidt RL; Veng-Pedersen P J Pharmacol Exp Ther; 2004 Jul; 310(1):202-8. PubMed ID: 14988424 [TBL] [Abstract][Full Text] [Related]
18. Mechanism for the nonlinear pharmacokinetics of erythropoietin in rats. Kato M; Kamiyama H; Okazaki A; Kumaki K; Kato Y; Sugiyama Y J Pharmacol Exp Ther; 1997 Nov; 283(2):520-7. PubMed ID: 9353365 [TBL] [Abstract][Full Text] [Related]
19. The pharmacokinetics of recombinant human erythropoietin in Balkan endemic nephropathy patients. Ležaić V; Petković N; Marić I; Miljković B; Vučićević K; Simić-Ogrizović S; Pejovic V; Djukanović L Nefrologia; 2013; 33(4):478-85. PubMed ID: 23897179 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic tracer kinetics analysis of changes in erythropoietin receptor population in phlebotomy-induced anemia and bone marrow ablation. Veng-Pedersen P; Chapel S; Al-Huniti NH; Schmidt RL; Sedars EM; Hohl RJ; Widness JA Biopharm Drug Dispos; 2004 May; 25(4):149-56. PubMed ID: 15108217 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]